Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo. (2015)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2015.10.003

PubMed Identifier: 26476879

Publication URI: http://europepmc.org/abstract/MED/26476879

Type: Journal Article/Review

Volume: 33

Parent Publication: Vaccine

Issue: 46

ISSN: 0264-410X